Angitia Biopharmaceuticals
Guangzhou · Founded 2018
About Angitia Biopharmaceuticals
Angitia Biopharmaceuticals is a global biotechnology company focusing on the discovery and development of innovative therapeutics for serious musculoskeletal diseases.
Company Facts
- Founded: 2018
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $406.0M
- Funding stage: Late Stage Venture
- Last round: Series D (Feb 2026)
- Website: https://angitiabio.com
- Phone: 206-232-9813
Industries & Categories
Biopharma, Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/angitia-biopharmaceuticals-3740 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.